Occult High-risk Disease in Clinically Low-risk Prostate Cancer with ≥50% Positive Biopsy Cores: Should National Guidelines Stop Calling Them Low Risk? - Urology

To identify contemporary, clinically low-risk patients with ≥50% cores positive and compare the risk of upgrading at prostatectomy with other low- or intermediate-risk patients.

Responses

Mr Jamie Dunn
·
ST6 Urology - Derriford Hospital
·
Posted about 4 years ago
This is not free access. For gaining a better understanding of managing low and low intermediate risk prostate cancer I suggest you review the PRIAS trial
Like
(0)
Respond